New hope for Pre-Cancer blood disorder? drug trial aims to boost cell counts
NCT ID NCT06788691
Summary
This study is testing if a drug called luspatercept can safely improve low blood cell counts in people with Clonal Cytopenia of Undetermined Significance (CCUS). CCUS is a condition where people have persistently low blood counts and genetic changes that put them at risk for developing more serious blood cancers. About 50 adults will receive luspatercept as an injection every three weeks to see if it raises their red blood cell, white blood cell, or platelet levels, improves their energy, and delays disease progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medical College
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.